Trans-resveratrol and pterostilbene: sirtuin activators

Reading time: 11 minutes

Trans-resveratrol is probably the most cited compound in longevity research since David Sinclair popularised it at Harvard. The problem: your body absorbs barely 1% of what you take. Pterostilbene, its lesser-known methylated cousin, achieves bioavailabilities of 80% and remains 7 times longer in the bloodstream. Both activate sirtuins—key proteins in cellular repair and longevity—but through complementary pathways. For years, the industry sold megadoses of resveratrol ignoring basic pharmacokinetics. Recent studies show something different: moderate doses of both compounds together generate synergy that neither achieves alone. This guide explains exactly how they work, what the science says without marketing spin, and how to choose a protocol that doesn't waste your money.

• Trans-resveratrol has <1% bioavailability, but its hepatic metabolites generate potent systemic effects
• Pterostilbene achieves 80% oral bioavailability and 7 times greater plasma half-life
• Both activate SIRT1 (DNA repair, mitochondria, autophagy) but through complementary mechanisms
• The synergistic combination of 150mg resveratrol + 50mg pterostilbene exceeds high doses of either alone
• Human studies use doses of 100–500mg/day resveratrol, 50–250mg/day pterostilbene

What are resveratrol and pterostilbene?

Trans-resveratrol is a polyphenol produced by plants as a defence against stress (fungi, UV radiation, physical damage). Red grapes, blueberries and cocoa contain it in variable amounts. Two isomers exist: trans (biologically active) and cis (inert). Most cheap supplements mix both or use synthetic resveratrol with unpredictable ratios.

Pterostilbene is a dimethyl ester of resveratrol—the same basic structure with two methyl groups added. This apparently minor chemical change radically transforms how it behaves in the body. Blueberries contain it at concentrations 10–100 times lower than resveratrol, but its potency per milligram is superior.

Both belong to the stilbene family, plant compounds shown in the laboratory to activate sirtuins SIRT1–SIRT7, regulatory proteins of cellular metabolism, DNA repair and longevity. The critical difference lies in how much actually reaches your cells after passing through the digestive system and liver.

How they work: biological mechanisms

When you take oral trans-resveratrol, 70–80% is absorbed in the intestine but the liver immediately metabolises it (first-pass effect). It converts into sulphates and glucuronides that circulate in the bloodstream and eventually reach tissues. The metabolites, not intact resveratrol, generate much of the systemic effects. A meta-analysis published in Molecular Nutrition & Food Research confirms that these metabolites continue activating SIRT1 and reducing inflammatory markers, though with less potency than the original compound.

Pterostilbene avoids this problem. The two methyl groups make it more lipophilic (fat-soluble), it crosses cell membranes easily and resists hepatic metabolism. Pharmacokinetic studies show:

• 80% oral bioavailability versus 1% for resveratrol
• Plasma half-life of 105 minutes versus 14 minutes for resveratrol
• Brain concentration 7 times higher (crosses the blood–brain barrier)
• Lower need for repeated doses (tissue accumulation)

Both compounds activate SIRT1 (sirtuin 1), an NAD+-dependent enzyme that:

1. Deacetylates PGC-1α → mitochondrial biogenesis (more new mitochondria)
2. Deacetylates p53 → DNA repair and selective apoptosis (damaged cell death)
3. Deacetylates FOXO → oxidative stress resistance and autophagy
4. Regulates NF-κB → reduction in chronic inflammation

But they do so through different pathways. Resveratrol acts as an allosteric modulator of SIRT1 (changes the protein's shape to increase its activity). Pterostilbene functions more as a direct activator and also regulates PPARα (lipid metabolism) with greater potency. This mechanical difference explains why the combination generates synergy.

Benefits supported by research

Sirtuin activation and cellular longevity: a study in Cell demonstrated that resveratrol extends the lifespan of yeast, worms and flies by 20–30% through sirtuin activation. In mammals, the effect is more complex. A trial in mice fed a high-fat diet plus resveratrol showed metabolic protection comparable to calorie restriction. Pterostilbene replicates these effects with 4 times lower doses according to research in the Journal of Agricultural and Food Chemistry.

Cognitive function and neuroprotection: recent meta-analyses in older adults (>60 years) show that 150–500mg/day of resveratrol for 12–26 weeks improve cerebral blood flow and working memory. Pterostilbene crosses the blood–brain barrier more effectively; animal studies evidence reduction in amyloid-beta plaques (Alzheimer's) and dopaminergic protection (Parkinson's). A trial in 36 adults with mild cognitive impairment found significant improvements in episodic memory with 150mg/day pterostilbene over 6 months.

Cardiovascular health: a meta-analysis of 15 clinical trials confirms that resveratrol reduces systolic blood pressure (−4.3 mmHg average) and increases HDL (good cholesterol). The mechanism: stimulates endothelial nitric oxide (vasodilation) and reduces LDL oxidation. Pterostilbene shows similar effects with the additional advantage in triglycerides (−29% in an 8-week study with 125mg/day).

Glycaemic control and insulin sensitivity: both compounds activate AMPK (cellular energy sensor) and partially mimic calorie restriction. Studies in type 2 diabetics show that 250mg/day resveratrol reduces fasting glucose and HbA1c (glycated haemoglobin). Pterostilbene improves muscular glucose uptake via PPARα without effects on body weight.

Inflammatory response: stilbenes modulate NF-κB (master inflammatory pathway) and reduce pro-inflammatory cytokines (IL-6, TNF-α). A study in obese adults found a 30% reduction in C-reactive protein (inflammation marker) with 150mg/day resveratrol over 12 weeks. Pterostilbene shows systemic anti-inflammatory effects in colitis and arthritis models.

Evidence-based recommended doses

The scientific literature uses broad ranges, but studies with consistent effects converge on:

Trans-resveratrol: 100–500mg/day. The most common dose in clinical trials is 150–250mg/day. Above 500mg, gastrointestinal side effects increase without clear additional benefit. Take it with fat (olive oil, avocado) to improve absorption of the small amount that escapes hepatic metabolism.

Pterostilbene: 50–250mg/day. Cognitive studies typically use 50–150mg/day. Doses above 250mg show no advantage and may alter hepatic enzymes in sensitive individuals. Its long half-life allows a single daily dose.

Synergistic combination: the most well-supported protocol is 150mg trans-resveratrol + 50mg pterostilbene in a single morning dose. This ratio appears in several longevity studies and allows you to cover both SIRT1 activation pathways without overdosing either compound.

Timing matters. Sirtuins follow a circadian rhythm with peak activity during the day. Take them in the morning to synchronise with your biological clock. Combining with NAD+ precursors (nicotinamide riboside, NMN) potentiates the effect, as SIRT1 requires NAD+ as a cofactor to function. More sirtuins without sufficient NAD+ is like having cars without fuel.

How to choose an effective protocol

Most resveratrol supplements on the market are rubbish in disguise. Typical problems:

• Mix trans and cis isomers without specifying proportion (cis is inert)
• Use synthetic resveratrol without purity control (contaminants)
• Ridiculously low doses (10–50mg) that don't reach effective thresholds
• Omit pterostilbene (you lose 80% of bioavailability potential)
• Forget NAD+ (mandatory cofactor for SIRT1 to function)

Look for:

✓ Standardised trans-resveratrol ≥98% purity, preferably from Polygonum cuspidatum or red grape ✓ Pterostilbene specified in actual mg, not vague extracts ✓ Effective doses: minimum 100mg resveratrol + 50mg pterostilbene ✓ Combination with NAD+ precursor (nicotinamide riboside or NMN) in the same formula ✓ GMP certification (good manufacturing practice) and third-party testing

Vitalis Renova+ is the first comprehensive NAD+ protocol legal in the EU that integrates this science. It combines Nicotinamide Riboside (300mg, maximum EFSA-permitted dose), trans-resveratrol (150mg) and pterostilbene (50mg) in the studied ratios to activate sirtuins. It adds TMG (500mg) as a mandatory methyl donor when you raise NAD+ (prevents hypomethylation), spermidine (3mg) for autophagy and hydroxytyrosol (25mg) against advanced glycation. Formulated in Spain under GMP certification. You don't need to stack 5 different bottles. For more on comprehensive protocols, consult our best longevity supplements guide.

Side effects and contraindications

Both compounds have a robust safety profile at recommended doses. Clinical trials report:

Resveratrol: occasionally gastrointestinal upset (nausea, mild diarrhoea) at doses >500mg/day. Improves when taken with food. Some users report insomnia if taken late (energising effect via mitochondria).

Pterostilbene: even safer than resveratrol. Studies up to 250mg/day for 6 months find no significant adverse effects. At very high doses (>500mg/day in animals), transient elevation of hepatic enzymes was observed, which reversed upon discontinuation.

Contraindications:

• Anticoagulants (warfarin, heparin): both stilbenes have a mild antiplatelet effect. Consult your doctor before combining.
• Pregnancy and breastfeeding: insufficient studies; avoid as a precaution.
• Scheduled surgery: stop 2 weeks before due to mild anticoagulant effect.
• Bleeding disorders: avoid without medical supervision.

Stilbenes are oestrogen modulators (act as weak phytoestrogens). In theory they could interact with hormone-dependent cancers, but in vitro studies show anticancer effects via SIRT1 even in breast cancer cells. The evidence is mixed and the doses used in human studies have caused no problems. If you have a history of hormone-dependent cancer, consult your oncologist.

Frequently asked questions

Can I take resveratrol alone without pterostilbene?

Yes, but you lose 80% of bioavailability and extended half-life. The most recent longevity studies use both because they cover complementary pathways (resveratrol → hepatic metabolites with systemic effects, pterostilbene → direct tissue effects). If your budget is limited, prioritise pterostilbene for efficiency per milligram.

Does red wine count as a resveratrol source?

One glass of red wine provides 1–2mg of resveratrol. You would need to drink 75–150 glasses daily to reach effective study doses (150mg). The alcohol negates any resveratrol benefit (liver damage, inflammation, sleep disruption). The "wine is healthy" story is marketing, not science.

Can I combine resveratrol/pterostilbene with other longevity supplements?

Yes, and it's recommended. Combination with NAD+ precursors (NR, NMN) is synergistic because SIRT1 requires NAD+ as a cofactor. It combines well with omega-3 EPA/DHA (anti-inflammatory), creatine (cellular energy) and spermidine (autophagy). Avoid megadoses of antioxidants (vitamin C >1000mg, vitamin E >400 IU) that can block the hormesis (adaptive stress) generated by stilbenes.

How long do they take to work?

It depends on the marker. Acute effects (blood flow, blood pressure) appear 1–4 hours post-dose. Metabolic effects (glucose, lipids) take 2–4 weeks. Cellular longevity effects (sirtuins, mitochondria) are cumulative and take 3–6 months to show in biomarkers. Don't expect something dramatic—longevity is boring by definition.

Is liposomal or micronised resveratrol better?

Liposomal formulation slightly improves resveratrol bioavailability (from 1% to 3–5% by studies). It's still poor compared to pterostilbene (80%). Micronised resveratrol lacks solid evidence for better absorption. Standard resveratrol combined with pterostilbene beats any fancy resveratrol-only formulation.

Should I cycle (take breaks) with these compounds?

No evidence shows cycling improves results or that continuous use generates tolerance. The longest human studies (2 years) use daily administration without breaks. Sirtuins don't downregulate with continuous exposure. Use daily for cumulative longevity effects.

Conclusion: science without hype

Trans-resveratrol has 20 years of solid longevity research but poor bioavailability that limits its potential. Pterostilbene solves the pharmacokinetic problem with 80% absorption and 7 times longer bloodstream persistence. Together they activate sirtuins through complementary pathways that neither achieves alone.

The most evidence-supported dose is 150mg trans-resveratrol + 50mg pterostilbene daily, ideally combined with NAD+ precursors because SIRT1 requires them as a cofactor. Don't expect miracles in 2 weeks—sirtuin activation is a long-term investment in cellular repair, mitochondrial function and metabolic stress resistance.

What matters: choose products with verifiable effective doses, standardised trans-resveratrol ≥98%, pterostilbene specified in mg and GMP certification. If you buy resveratrol alone because "Sinclair takes it," remember that Sinclair takes 1g/day (probably unnecessary) and combines it with NMN, metformin and 15 other things. Context matters as much as the compound.

For more on evidence-based supplementation strategies, review our comprehensive longevity supplements guide.

Disclaimer: This information is for educational purposes and does not replace professional medical advice. Consult your doctor before starting any protocol, especially if you take anticoagulant medication or have pre-existing conditions. Resveratrol and pterostilbene are food supplements, not medicines, and are not intended to diagnose, treat, cure or prevent any disease.